These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19932171)

  • 1. Resistance of the dopamine D4 receptor to agonist-induced internalization and degradation.
    Spooren A; Rondou P; Debowska K; Lintermans B; Vermeulen L; Samyn B; Skieterska K; Debyser G; Devreese B; Vanhoenacker P; Wojda U; Haegeman G; Van Craenenbroeck K
    Cell Signal; 2010 Apr; 22(4):600-9. PubMed ID: 19932171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLHL12-mediated ubiquitination of the dopamine D4 receptor does not target the receptor for degradation.
    Rondou P; Skieterska K; Packeu A; Lintermans B; Vanhoenacker P; Vauquelin G; Haegeman G; Van Craenenbroeck K
    Cell Signal; 2010 Jun; 22(6):900-13. PubMed ID: 20100572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin.
    Deming JD; Shin JA; Lim K; Lee EJ; Van Craenenbroeck K; Craft CM
    Cell Signal; 2015 Oct; 27(10):2002-13. PubMed ID: 26169958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interaction between the dopamine D4 receptor, KLHL12 and β-arrestins.
    Skieterska K; Shen A; Clarisse D; Rondou P; Borroto-Escuela DO; Lintermans B; Fuxe K; Xiang YK; Van Craenenbroeck K
    Cell Signal; 2016 Aug; 28(8):1001-14. PubMed ID: 27155323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
    Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
    J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
    Qian H; Pipolo L; Thomas WG
    Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in motilin receptor desensitization after stimulation with motilin or motilides are due to alternative receptor trafficking.
    Mitselos A; Vanden Berghe P; Peeters TL; Depoortere I
    Biochem Pharmacol; 2008 Mar; 75(5):1115-28. PubMed ID: 18096134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.
    Cho DI; Beom S; Van Tol HH; Caron MG; Kim KM
    Biochem Biophys Res Commun; 2006 Nov; 350(3):634-40. PubMed ID: 17022946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells.
    Newman-Tancredi A; Heusler P; Martel JC; Ormière AM; Leduc N; Cussac D
    Int J Neuropsychopharmacol; 2008 May; 11(3):293-307. PubMed ID: 17897483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.
    Hong MH; Xu C; Wang YJ; Ji JL; Tao YM; Xu XJ; Chen J; Xie X; Chi ZQ; Liu JG
    J Neurochem; 2009 Jan; 108(1):102-14. PubMed ID: 19014372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization.
    Teli T; Markovic D; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2005 Feb; 19(2):474-90. PubMed ID: 15498832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
    Shinyama H; Masuzaki H; Fang H; Flier JS
    Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
    Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action.
    Navratilova E; Waite S; Stropova D; Eaton MC; Alves ID; Hruby VJ; Roeske WR; Yamamura HI; Varga EV
    Mol Pharmacol; 2007 May; 71(5):1416-26. PubMed ID: 17322005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of rare variants in human dopamine receptor D4 gene by genotype-phenotype correlations.
    Michealraj KA; Jatana N; Jafurulla ; Narayanan L; Chattopadhyay A; Thelma BK
    Neuroscience; 2014 Mar; 262():176-89. PubMed ID: 24406443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site.
    Neuschäfer-Rube F; Hermosilla R; Rehwald M; Rönnstrand L; Schülein R; Wernstedt C; Püschel GP
    Biochem J; 2004 May; 379(Pt 3):573-85. PubMed ID: 14709160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
    Fessart D; Simaan M; Laporte SA
    Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine.
    Czermak C; Lehofer M; Liebmann PM; Traynor J
    Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.
    Cummings DF; Ericksen SS; Goetz A; Schetz JA
    J Pharmacol Exp Ther; 2010 Jun; 333(3):682-95. PubMed ID: 20215412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.
    Stanasila L; Abuin L; Dey J; Cotecchia S
    Mol Pharmacol; 2008 Sep; 74(3):562-73. PubMed ID: 18523139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.